Individualized Therapy for Specific Infections Associated with Bronchiectasis
May 1st 2024A medical expert discusses the various types of bacteria and fungi that can grow in the lungs and sputum of bronchiectasis patients, such as Pseudomonas aeruginosa, emphasizing the importance of an individualized approach to treatment, and notes that while fungal cultures may be positive, they may not always be clinically significant.
Patient Specific Factors: Guiding Treatment in Bronchiectasis
April 24th 2024Pamela J. McShane, MD, explains her approach to diagnosing the underlying cause of bronchiectasis, which includes identifying cystic fibrosis in older patients, and emphasizes the importance of helping patients lead a normal life while managing their condition.
Social Burden and Goals of Therapy for Patients with Bronchiectasis
April 17th 2024A medical professional addresses the social aspects of bronchiectasis, emphasizing patients' embarrassment due to productive coughing in public spaces like grocery stores and churches, as well as the psychological challenges of planning travel and vacations due to the unpredictability of exacerbations, which can lead to social isolation.
Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words
April 16th 2024Robert Gabbay, MD, PhD, gives closing thoughts and advocates that continuous glucose monitors should be supplied for all insulin-dependent diabetes patients, including at initial diagnosis, to facilitate self-management and tighter control of this disease.
Achieving Equitable Representation in Clinical Studies
April 15th 2024The panel has an in-depth discussion on improving diversity in clinical trials. They discuss ways to increase minority participation through community partnerships, including providing transportation, lodging, and other resources needed to enable participation.
Diagnosing and Understanding the Pathogenesis of Bronchiectasis
March 27th 2024Pamela J. McShane, MD, explores the clinical manifestations of bronchiectasis, including productive chronic cough, hemoptysis, and recurrent respiratory infections, while emphasizing the importance of CT scans in revealing improper airway narrowing and addressing the misdiagnosis of COPD and asthma.
Coverage of Gene Therapies: Balancing Cost, Clinical Impact, and Durability of Effect
March 26th 2024Ryan Haumschild, PharmD, MS, MBA, leads a discussion on factors that influence coverage of non-oncology gene therapies, exploring the balance between long-term cost savings and high initial prices, patient selection, and the durability of effect for these therapies.